Heron Therapeutics | HRTX - ДОЛГ





ДОЛГ Изменить Дата
ALKERMES USD 1.58B 1.51B 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 613.76M 3.28M 2026-03
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 983.69M 5.77M 2026-06
Eisai JPY 186.08B 50.58B 2026-03
Emergent BioSolutions USD 903.2M 495.2M 2023-06
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 725.8M 1.82M 2026-06
Ligand Pharmaceuticals USD 451.98M 486K 2026-03
Merck USD 49.12B 222M 2026-03
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
Omeros USD 442.16M 199K 2023-09
Pacira USD 363.12M 4.53M 2026-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Veracyte USD 39.33M 321K 2026-03
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06